42
Munich Vascular Conference Venous Symposium, 9.12.2017 Is there any evidence that endovenous laser therapy or radiofrequency or foam sclerotherapy is superior to each other ? Department for Vascular Surgery Diakonie-Klinikum, Schwäbisch Hall, Germany C.-G. Schmedt

Is there any evidence that endovenous laser therapy or ......EVRF F-Care. Munich Vascular Conference Venous Symposium, 9.12.2017. Segmental Radiofrequency Ablation. Closure. FAST Procedure

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    Is there any evidence that endovenous laser therapy

    or radiofrequency or foam sclerotherapy

    is superior to each other ?

    Department for Vascular Surgery

    Diakonie-Klinikum, Schwäbisch Hall, Germany

    C.-G. Schmedt

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    Disclosure

    I have the following potential conflicts of interest

    to report:

    Receipt of grants/research support

    Receipt of honoraria and travel support

    Participation in a company sponsored

    speakers‘ bureau

    Employment in industry

    Shareholder in a healthcare company

    Owner of a healthcare company

    I do not have any potential conflict of interest

  • Which is the best treatment for my patient ?

    David L Sackett (1996) BMJ 312:71-72

    „Evidence based medicine is

    no cookbook medicine ...

    ... integrates the best external evidence with

    individual clinical experience and

    patients´ choice ... “

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • 2013

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Bountouroglou (2006)

    Hamel-Desnos (2007)

    Abela (2008)

    Rabe (2008)

    Gonzalez-Zeh (2008)

    3 m

    24 m

    0,5 m

    3 m

    12 m

    13 %

    31 %

    k.A.

    31% (4%-61%)

    23%

    Author Follow-up

    Recurrent

    reflux in GSV

    Randomized Controlled Trials (RCT, 1b)

    Patients

    n= 30

    n= 74

    n= 30

    n=106

    n= 53

    Foam sclerotherapy for GSV

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Painscore

    Usual activity

    Return to work

    Reflux [12 Mo.]

    LaserRFA (CLF) Foam Stripping

    2.58

    2 d

    3.6 d

    5.8 %

    1.21

    1 d

    2.9 d

    4.8%

    Rasmussen LH et al. (2011)

    Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation,

    foam sclerotherapy and surgical stripping for great saphenous varicose veins.

    Br J Surg 2011; 98:1079-1087. Evidence level: 1b

    1.60

    1 d

    2.9 d

    16.3%

    2.25

    4 d

    4.3 d

    4.8%

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Recanalisation [5 Y]

    Rec. varicose veins

    Re-treatment

    Laser Foam Stripping

    6.8%

    38.6%

    18.7%

    5.8%

    18.7%

    17.0%

    Lawaetz M, Serup J, Lawaetz B, Bjoern L, Blemings B, Eklof B, Rasmussen L (2017)

    Comparison of endovenous ablation techniques, foam sclerotherapy and surgical

    stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT

    Int Angiol 2017; 36:281-288. Evidence level: 1b

    31.5%

    31.7%

    37.7%

    6.3%

    34.6%

    23.4%

    RFA (CLF)

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Occlusion [1Y]

    Reflux below knee [1Y]

    Sick leave

    Haematoma [1mo]

    Pigmentation [1mo]

    Laser Foam Stripping

    97%

    16%

    8d

    42%

    4%

    51%

    33%

    1d

    20%

    67%

    97%

    13%

    12d

    62%

    5%

    Venermo M, Saarinen J, Eskelinen et al. (2016)

    Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided

    foam sclerotherapy for the treatment of great saphenous varicose veins.

    Br J Surg 2016; 103:1438-1444. Evidence level: 1b

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Venermo M, Saarinen J, Eskelinen et al. (2016)

    Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided

    foam sclerotherapy for the treatment of great saphenous varicose veins.

    Br J Surg 2016; 103:1438-1444. Evidence level: 1b

    Disease-specific quality of life (AVVSS)

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    Evidence level: 1b

  • Shepherd AC et al. (2010)

    Randomized clinical trial of VNUS Closure FAST radiofrequency ablation versus laser for varicose veins.

    Br J Surg 2010; 97: 810-818. Evidence level 1b

    Pain level 3d

    Pain level 10d

    Analgesics 10d

    26.4

    22.0

    20.4

    36.8

    34.3

    35.9

    0.010

    0.001

    0.001

    ClosureFAST

    n= 67

    ELT (980nm, bare)

    n= 64 p-value

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Almeida JI, Kaufmann J, Göckeritz O, Chopra P, Evans MT, Hoheim DF, Makhoul RG, Richards T, Wenzel C,

    Raines JK (2009) Radiofrequency Endovenous ClosureFAST versus Laser Ablation for the Treatment of Great

    Saphenous Reflux: A Multicenter, Single-blinded, Randomized Study (RECOVERY Study).

    J Vasc Interv Radiol 2009; 20: 752-759. Evidence level: 1b

    ClosureFAST

    n= 46

    ELT (980nm, bare)

    n= 41

    Ekchymosis

    Phlebitis

    Paresthesia

    Erythema

    Hyperpigmentation

    15 (33,3%)

    0

    1 (2,2%)

    0

    1 (2,2%)

    33 (81,5%)

    6 (14,6)

    2 (4,9%)

    4 (9,8%)

    0

    p-value

    < 0,0001

    0,009

    n.s.

    0,045

    n.s.

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • He G, Zheng C, Yu MA, Zhang H (2017)

    Comparison of ultrasound-guided endovenous laser ablation and radiofrequency for the varicose

    veins treatment: An updated meta-analysis.

    International Journal of Surgery 2017; 39: 267-275. Evidence level: 1a

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    He G, Zheng C, Yu MA, Zhang H (2017)

    Comparison of ultrasound-guided endovenous laser ablation and radiofrequency for the varicose

    veins treatment: An updated meta-analysis.

    International Journal of Surgery 2017; 39: 267-275. Evidence level: 1a

    • Conclusion

    EVLA and RFA seem to be the same in respect to safety and efficacy

    (ablated length, 3days and 10days pain scores, 1 month, 1 year quality of life,

    occlusion, thrombophlebitis, haematoma and recanalisation).

  • Paravastu SC, Horne M, Dodd PD.

    Endovenous ablation therapy (laser or

    radiofrequency) or foam sclerotherapy

    versus conventional surgical repair for short

    saphenous varicose veins.

    Cochrane Database Syst Rev. 2016 Nov

    29;11:CD010878.

    Nesbitt C, Bedenis R, Bhattacharya V, Stansby G.

    Endovenous ablation (radiofrequency and laser)

    and foam sclerotherapy versus open

    surgery for great saphenous vein varices.

    Cochrane Database Syst Rev. 2014 Jul

    30;(7):CD005624. doi:

    10.1002/14651858.CD005624.pub3.

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

    http://www.google.de/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&ved=0ahUKEwij_5SIp_jXAhUEDOwKHaEOCMEQjRwIBw&url=http://retractionwatch.com/2010/09/20/progressive-how-the-cochrane-library-handles-updates-in-progress/&psig=AOvVaw0r17PKbERrlMg6paolG427&ust=1512749947807292

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    Problems of endovenous literature

    • Dubiously powered

    • Heterogeneous endpoints

    • Potential conflict of interest

    • Short follow-up

    • Incomplete outcome data

    • Wide selection of treatment options

    • New treatment protocols

  • Endovenous

    Thermal Ablation

    Endovenous

    Non-thermal Ablation

    • Foam sclerotherapy

    • Mechano-chemical(MOCA, Clarivein)

    • Glue (Cyanoacrylate)(CAVA, VenaSeal)

    Treatment options of truncal vein insufficiency

    • Radiofrequency(CLF, RFITT, EVRF)

    • LASER(810-1940nm, Bare, Radial)

    • Steam

    • Crossectomy

    • Stripping

    • CHIVA

    • ASVAL

    • Valvuloplasty

    Conventional

    Open

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Bare Fiber

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Histology (HE) Optical Coherence Tomography

    (OCT)

    Schmedt CG, Meissner OA, Hunger K, Babaryka G, Ruppert V, Sadeghi-Azandaryani M, Steckmeier BM, Sroka R.

    Evaluation of endovenous radiofrequency ablation and laser therapy with endoluminal optical coherence tomography in

    an ex vivo model. J Vasc Surg 2007; 45: 1047-1058.

    ELT with Bare Fiber - Perforations of vein wall

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Radial Fiber

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Higher absorption in water at long wavelengths

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • P=15W

    LEED=150J/cm

    Carbonisation

    Perforation

    P=6W

    LEED=60J/cm

    Circular thermal

    alteration

    P=3W

    LEED=30J/cm

    Circular thermal

    alteration

    Vacuolisation

    Delamination

    λ = 980nm / bare fibre λ = 1470nm λ = 1940nm

    Sroka R et al.

    Laser-Forschungslabor, LIFE-Center, LMU München

    Experimental comparison ELT 980nm vs 1470nm vs 1940nm

  • 1-4 weeks 6 months 1 year 2 years

    Paresthesia 8.5% (15/177) 5.6% (9/160) 3.8% (5/129) 3.9% (5/127)

    Thrombuspropagation (EHIT) 2.3% (4/177) 0% 0% 0%

    Ecchymosis 2.3% (4/177) 0% 0% 0%

    Lymphocele 0.6% (1/177) 0% 0% 0%

    Pigmentation 0.6% (1/177) 1.3% (2/160) 0% 0%

    Phlebitis 0% 0% 0% 0%

    Recanalisation 0% 0% 0.8% (1/129) 1.6% (2/127)

    Epifascial reflux (AASV) 0% 0% 0.8% (1/129) 2.4% (3/127)

    ELT (Tm, 1940nm) n=177 (own data)

  • T3 W4 M6 J1 J2

    Non-

    occlusi

    on

    0.5 cm(0-3.4 cm)

    0.6 cm(0-3.8 cm)

    0.7 cm(0-2.0 cm)

    0.7 cm(0-3.2 cm)

    0.7 cm(0-4.0 cm)

    DVTD(Deep

    vein

    thrombus

    distance)

    0.4 cm(0-2.7 cm)

    0.4 cm(0-3.3 cm)

    0.4 cm(0-2.0 cm)

    0.5 cm(0-2.5 cm)

    0.5 cm(0-3.5 cm)

    DVTD

    Non-

    Occlusion

    ELT (Tm, 1940nm) n=177 (own data)

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    Evidence level: 1b

  • Doganci S, Demirkiliz U (2010)

    Eur J Vasc Endovasc Surg 40: 254-259 Evidence level: 1b

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • ELT (1470nm) Bare Fibern= 168

    Radial Fiber

    n= 144

    Occlusion rate (3 Mo.)

    Phlebitis

    Paresthesia

    Ecchymosis / Hematoma

    No analgesics

    Analgesics (Doses)

    100%

    1,8%

    0%

    83,9%

    21,4%

    103 mg

    100%

    2,1%

    0%

    63,9%

    35,4%

    82 mg

    0,0001

    0,04

    p-Wert

    Schwarz T, von Hodenberg E, Furtwängler C, Rastan A, Zeller T, Neumann FJ

    Endovenous laser ablation of varicose veins with the 1470nm diode laser.

    J Vasc Surg 2010 51:1474-1478. Evidence level: 2b.

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Hirokawa M, Kurihara N (2014)

    Comparison of Bare Tip and Radial Fiber in Endovenous Laser Ablation with 1470nm Diode Laser.

    Ann Vasc Dis 2014; 239-245. Evidence level: 3b

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Bozoglan O, Mese B, Eroglu E, Ekerbicer, Yasim A (2017)

    Comparison of Endovenous Laser and Radiofrequency Ablation in treating varices in the same

    patient.

    Journal of Lasers in Medical Sciences 2017; 8:13-16. Evidence level: 2b

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Evidence based Evaluation

    • Safety

    • Effectiveness

    • Patients comfort

    • Costs

    FoamRFA

    +

    -

    ++

    +

    +

    (+)

    +

    -

    Laser

    +

    (+)

    +

    -

    Stripping

    +

    +

    -

    (+)

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    • Reduced effectiveness of foam sclerotherapy

    • No significant difference between RFA and Laser

    • Heterogeneity of study designs

    • Evidence level moderate-low

    • Continuous technical development

    • Laser: Long wave length and radial fiber

    • More trials with well defined endpoints needed

    Summary

  • Foam Sclerotherapy

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Bipolar Radiofrequency Ablation

    VNUS Closure PLUS Olympus Celon RFITT

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Endovenous Radiofrequency Ablation

    EVRF F-Care

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Segmental Radiofrequency Ablation

    Closure FAST Procedure

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Bare Fibre980nm 20W 1mm/s

    ELVeS Radial1470nm 6W 1mm/s

    rigid – shrinkage

    charring from blood

    rigid – shrinkage

    white coagulated tissue

    Exp. approach clinical gain: comparable in rigidnes

    Sroka R, Pongratz T, Siegrist K, Burgmeier C, Barth H.-D., Schmedt CG (2013)

    Endoveous Laser Application: Stategies to improve energy application

    Phlebologie 2013; 42: 117-176

    Munich Vascular Conference

    Venous Symposium, 9.12.2017

  • Transversal „Donut“

    after ELT (1940nm)

  • Longitudinal „Cookie“

    after ELT (1940nm)

  • No stump after ELT (1940nm)

    Sapheno-femorale junction longitudinal

  • Munich Vascular Conference

    Venous Symposium, 9.12.2017

    Level Therapy / Prevention, Aetiology / Harm

    1a Systematic Review of RCTs

    1b Individual RCT

    1c All or none

    2a Systematic Review of cohort studies

    2b Individual cohort study (including low quality RCT)

    2c “Outcomes” Research; Ecological studies

    3a Systematic Review of case-control studies

    3b Individual Case-Control Study

    4 Case-series

    5 Expert opinion

    Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since November 1998. Updated by Jeremy Howick March 2009

    Levels of Evidence (CEBM Oxford)